Blog
Online prescriber consultations – what are the pros and cons?
Pros Convenience, the consultation can take place in your own home at any time of day. No time needs to be taken off work to attend the consultation. Treatment can be obtained quicker if required. The service is cheaper to deliver than a face to face consultation....
Pregabalin and Gabapentin to be reclassified in April 2019.
The Home Office has announced that Pregabalin and Gabapentin will be reclassified from a Prescription Only Medicine (POM) to a Schedule 3 Controlled Drug in April 2019. What does this mean for wholesalers and pharmacies? Well for pharmacies, the storage of these two...
Epipen Shortages. Have you been affected?
The life-saving adrenaline auto-injectors, Epipen, are still unavailable for the public due to manufacturing issues. This is a serious issue that could affect one’s life. Mylan, the manufacturer, had explained the delay was due to ‘interruptions in the production of...
Brexit – The evidence against is building and time is running out !
In June BMA representatives voted by a large majority against Brexit, they called for a public vote on any exit deal, yet apart from a few brave souls, many do not voice their opinions. But there is evidence pilling up that Brexit rather than filling the NHS coffers...
Pharmacy must get ready for FMD, or they may face prosecution.
Pharmacists must be able to carry out the 2 step Authentication processes of FMD by February 2019 or they may not be able to trade. If they trade without carrying out the required FMD checks they may face an unlimited fine or a custodial sentence. Standing still is...
The experience of the 50+ generation and the enthusiasm of youth are unstoppable!
The 50 something? I hate to admit elderly team members may not be able to compete with the knowledge of the younger team members who have vast digital intelligence. However, we tend to be the generation with more emotional intelligence and experience led judgement....
What do you want to do?
What do you want to do? Provide Information. When do you want to give it to us? Ummmm… OK, you might have been more definite in your final answer. But was it what the MHRA Inspector wanted to hear? Or see in your SOP’s? Particularly with regards to information on...
The “Buy Medicines online” debate. How would you evaluate the risks?
Whilst the healthcare agencies criticise the online purveyors of medicines with their pharmacist prescribers to avoid CQC registration. The CQC registered pharmacies which employ European prescribers some of whom lack the controls in place to ensure effective and safe...
Health Service Products (Provision and Disclosure of Information) Regulations 2018
I am sure plenty has been written and said about what I am sure many will see as an additional burden on wholesalers, this simple post is to help provide clarity about the scope of the regulations…
The ‘Making’ of a Good Responsible Person
Despite the MHRA’s guidance note 6 there is a lack of a clearly defined and standardised route into becoming a trained, experienced, and effective Responsible Person (RP), and consequently the MHRA are now placing a greater emphasis on the suitability of a licence holder’s RP, perhaps in an attempt to ensure that all roads eventually lead to the same destination or to gradually develop and define the necessary route, or maybe both…
Standards for Everyone…
For the last 3 years, when delivering GDP Training, and when it comes to the subject of Transportation – and the related GDP requirements – there has always been stock comments and specific observations…
Will the regulators be able to handle all this extra regulatory work ?
The EMA( European Medicines Agency) set up a task force to prepare for the possible eventualities of the UK referendum. They had several areas of concern the main one being the potential disruption to the supply chain of medicines and the impact in public health. The...